Dexamethasone exposure during the neonatal period alters ORL1 mRNA expression in the hypothalamic paraventricular nucleus and hippocampus of the adult rat

Developmental Brain Research

Volumn 146, Issue 1-2, 2003, Pages 15-24

  Neal Jr , Charles R ^a,b   VanderBeek, Brian L ^a   Vázquez, Delia M ^a,b   Watson Jr , Stanley J ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Glucocorticoid; In situ hybridization; Limbic system; Neurodevelopment; Nociceptin; Orphanin FQ

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; NOCICEPTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DENTATE GYRUS; EXPERIMENTAL MODEL; FEMALE; HIPPOCAMPUS; HISTOCHEMISTRY; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; OXIDATIVE STRESS; PERINATAL PERIOD; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR OCCUPANCY; SPECIES COMPARISON; TISSUE FIXATION; TISSUE SECTION;

ANIMALIA;

EID: 0344395627     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devbrainres.2003.09.002     Document Type: Article

References (92)

1. Alexis M.N., Kitraki E., Spanou K., Stylianopoulou F., Sekeris C.E. Ontogeny of the glucocorticoid receptor in the rat brain. Adv. Exp. Med. Biol. 265:1990;269-276.
2. Altman J., Das G.D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Comp. Neurol. 124:1965;319-335.
3. Altman J., Das G.D. Post-natal origin of microneurones in the rat brain. Nature. 207:1965;953-956.
4. Altman J., Das G.D. Autoradiographic and histological studies of postnatal neurogenesis: I. A longitudinal investigation of the kinetics, migration and transformation of cells incorporating tritiated thymidine in neonate rats, with special reference to postnatal neurogenesis in some brain regions. J. Comp. Neurol. 126:1966;337-389.
5. Amano T., Matsubayashi H., Tamura Y., Takahashi T. Orphanin FQ-induced outward current in rat hippocampus. Brain Res. 853:2000;269-274.
6. Brain P., Benton D. The interpretation of physiological correlates of differential housing in laboratory rats. Life Sci. 24:1979;99-115.
7. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett. 347:1994;284-288.
8. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C.A., Yu L. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347:1994;279-283.
9. Civelli O., Nothacker H.P., Bourson A., Ardati A., Monsma F., Reinscheid R. Orphan receptors and their natural ligands. J. Recept. Signal Transduct. Res. 17:1997;545-550.
10. Connor M., Christie M.D. Opioid receptor signaling mechanisms. Clin. Exp. Pharmacol. Physiol. 26:1999;493-499.
11. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br. J. Pharmacol. 119:1996;1614-1618.
12. Connor M., Vaughan C.W., Jennings E.A., Allen R.G., Christie M.J. Nociceptin, Phe(1)psi-nociceptin(1-13), nocistatin and prepronociceptin(154-181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro. Br. J. Pharmacol. 128:1999;1779-1787.
13. Devine D.P., Reinscheid R.K., Monsma F.J. Jr., Civelli O., Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727:1996;225-229.
14. Devine D.P., Taylor L., Reinscheid R.K., Monsma F.J. Jr., Civelli O., Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem. Res. 21:1996;1387-1396.
15. Devine D.P., Watson S.J., Akil H. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis. Neuroscience. 102:2001;541-553.
16. Devine D.P., Hoversten M.T., Ueda Y., Akil H. Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress. J. Neuroendocrinol. 15:2003;69-74.
17. Diaz R., Brown R.W., Seckl J.R. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions. J. Neurosci. 18:1998;2570-2580.
18. Flagel S.B., Vazquez D.M., Watson S.J. Jr., Neal C.R. Jr. Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. Am. J. Physiol., Regul. Integr. Comp. Physiol. 282:2002;R55-R63.
19. Florin S., Suaudeau C., Meunier J.C., Costentin J. Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur. J. Pharmacol. 317:1996;9-13.
20. Florin S., Suaudeau C., Meunier J.C., Costentin J. Orphan neuropeptide NocII, a putative pronociceptin maturation product, stimulates locomotion in mice. NeuroReport. 8:1997;705-707.
21. Frisone D.F., Frye C.A., Zimmerberg B. Social isolation stress during the third week of life has age-dependent effects on spatial learning in rats. Behav. Brain Res. 128:2002;153-160.
22. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., Sugimoto T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1994;42-46.
23. Fuxe K., Wikstrom A.C., Okret S., Agnati L.F., Harfstrand A., Yu Z.Y., Granholm L., Zoli M., Vale W., Gustafsson J.A. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology. 117:1985;1803-1812.
24. Gavioli E.C., Marzola G., Guerrini R., Bertorelli R., Zucchini S., De Lima T.C., Rae G.A., Salvadori S., Regoli D., Calo G. Blockade of nociceptin/orphanin FQ-NOP receptor signaling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur. J. Neurosci. 17:2003;1987-1990.
25. Griebel G., Perrault G., Sanger D.J. Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Res. 836:1999;221-224.
26. Hall F.S., Huang S., Fong G. Effects of isolation-rearing on acoustic startle and pre-pulse inhibition in Wistar and fawn hooded rats. Ann. N.Y. Acad. Sci. 821:1997;542-544.
27. Hall F.S., Huang S., Fong G.F., Pert A. The effects of social isolation on the forced swim test in Fawn hooded and Wistar rats. J. Neurosci. Methods. 79:1998;47-51.
28. Hall F.S., Huang S., Fong G.W., Pert A., Linnoila M. Effects of isolation-rearing on locomotion, anxiety and responses to ethanol in Fawn Hooded and Wistar rats. Psychopharmacology (Berl.). 139:1998;203-209.
29. Hao J.X., Wiesenfeld-Hallin Z., Xu X.J. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci. Lett. 223:1997;49-52.
30. Hara N., Minami T., Okuda-Ashitaka E., Sugimoto T., Sakai M., Onaka M., Mori H., Imanishi T., Shingu K., Ito S. Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br. J. Pharmacol. 121:1997;401-408.
31. Heidbreder C.A., Weiss I.C., Domeney A.M., Pryce C., Homberg J., Hedou G., Feldon J., Moran M.C., Nelson P. Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome. Neuroscience. 100:2000;749-768.
32. Hiramatsu M., Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur. J. Pharmacol. 367:1999;151-155.
33. Hiramatsu M., Inoue K. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice. Br. J. Pharmacol. 127:1999;655-660.
34. Hiramatsu M., Inoue K. Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory. Eur. J. Pharmacol. 395:2000;149-156.
35. Houtani T., Nishi M., Takeshima H., Nukada T., Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem. Biophys. Res. Commun. 219:1996;714-719.
36. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J. Jr., Nothacker H.P., Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U. S. A. 94:1997;14854-14858.
37. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.L., Ouagazzal A.M., Martin J.R., Lundstrom K., Cesura A.M., Poli S.M., Roever S., Kolczewski S., Adam G., Kilpatrick G. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4938-4943.
38. Knoflach F., Reinscheid R.K., Civelli O., Kemp J.A. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J. Neurosci. 16:1996;6657-6664.
39. Koster A., Montkowski A., Schulz S., Stube E.M., Knaudt K., Jenck F., Moreau J.L., Nothacker H.P., Civelli O., Reinscheid R.K. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;10444-10449.
40. Kotlinska J., Suder P., Legowska A., Rolka K., Silberring J. Orphanin FQ/nociceptin inhibits morphine withdrawal. Life Sci. 66:2000;PL119-PL123.
41. Lachowicz J.E., Shen Y., Monsma F.J. Jr., Sibley D.R. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J. Neurochem. 64:1995;34-40.
42. Lanier L.P., Isaacson R.L. Early developmental changes in the locomotor response to amphetamine and their relation to hippocampal function. Brain Res. 126:1977;567-575.
43. Lapiz M.D., Fulford A., Muchimapura S., Mason R., Parker T., Marsden C.A. Influence of postweaning social isolation in the rat on brain development, conditioned behavior, and neurotransmission. Neurosci. Behav. Physiol. 33:2003;13-29.
44. Le Cudennec C., Naudin B., Do Rego J.C., Costentin J. Nociceptin/ orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection. Life Sci. 72:2002;163-171.
45. Ma L., Cheng Z.J., Fan G.H., Cai Y.C., Jiang L.Z., Pei G. Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma×glioma NG108-15 hybrid cells. FEBS Lett. 403:1997;91-94.
46. Madamba S.G., Schweitzer P., Siggins G.R. Nociceptin augments K(+) currents in hippocampal CA1 neurons by both ORL-1 and opiate receptor mechanisms. J. Neurophysiol. 82:1999;1776-1785.
47. Martin-Fardon R., Ciccocioppo R., Massi M., Weiss F. Nociceptin prevents stress-induced ethanol-but not cocaine-seeking behavior in rats. NeuroReport. 11:2000;1939-1943.
48. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B.et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
49. Minami T., Okuda-Ashitaka E., Nishizawa M., Mori H., Ito S. Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. Br. J. Pharmacol. 122:1997;605-610.
50. Misilmeri M.A., Fernandez F., Felger J.C., Devine D.P. Intracerebroventricular microinjections of N/OFQ produce anxiogenic effects in neophobic tests of anxiety. Abstr. - Soc. Neurosci. 28:2002;571.11.
51. Mogil J.S., Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53:2001;381-415.
52. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J.C. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
53. Murphy N.P., Lee Y., Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832:1999;168-170.
54. Narayanan S., Maidment N.T. Orphanin FQ and behavioral sensitization to cocaine. Pharmacol. Biochem. Behav. 63:1999;271-277.
55. Narayanan S., Lutfy K., Maidment N. Sensitization to cocaine after a single intra-cerebral injection of orphanin FQ/nociceptin. Behav. Brain Res. 131:2002;97-103.
56. Neal C.R. Jr., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., Watson S.J. Jr. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol. 412:1999;563-605.
57. Neal C.R. Jr., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Watson S.J. Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406:1999;503-547.
58. Neal C.R. Jr., Akil H., Watson S.J. Jr. Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain. J. Chem. Neuroanat. 22:2001;219-249.
59. Neal C.R. Jr., Weidemann G., Watson S.J., Vazquez D.M. Effect of a prolonged course of neonatal dexamethasone on growth, neurological development and response to stress in the adult rat. Soc. Pediatr. Res. Abstr. 2001.
60. Neal C.R. Jr., Vanderbeek B., Watson S.J., Vazquez D.M. Effect of a prolonged course of neonatal dexamethasone on corticotropin releasing hormone, mineralocorticoid receptor and glucocorticoid receptor gene expression in the adult rat. Abstr. - Soc. Neurosci. 28:2002;274.9.
61. Neal C.R. Jr., Akil H., Watson S.J. Jr. Neuroanatomical studies of the opioid receptor-like-1 receptor and its endogenous neuropeptide orphanin FQ (nociceptin). Quirion R., Björklund A., Hökfelt T. Handbook of Chemical Neuroanatomy. vol. 20:2003;103-193 Elsevier, Amsterdam.
62. Neal C.R. Jr., Owens C.E., Taylor L.P., Hoversten M.T., Akil H., Watson S.J. Jr. Binding and GTPγS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors. J. Chem. Neuroanat. 25:2003;233-247.
63. Netti C., Rapetti D., Sibilia V., Pagani F., Pecile A., Guidobono F. Endocrine effects of centrally injected nociceptin in the rat. Brain Res. 938:2002;55-61.
64. Nicholson J.R., Akil H., Watson S.J. Orphanin FQ-induced hyperphagia is mediated by corticosterone and central glucocorticoid receptors. Neuroscience. 115:2002;637-643.
65. Nicol B., Lambert D.G., Rowbotham D.J., Smart D., McKnight A.T. Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices. Br. J. Pharmacol. 119:1996;1081-1083.
66. Olszewski P.K., Billington C.J., Levine A.S. Fos expression in feeding-related brain areas following intracerebroventricular administration of orphanin FQ in rats. Brain Res. 855:2000;171-175.
67. Olszewski P.K., Grace M.K., Billington C.J., Levine A.S. The effect of [Phe(1)psi(CH(2)-NH)Gly(2)]-nociceptin(1-13)NH(2) on feeding and c-Fos immunoreactivity in selected brain sites. Brain Res. 876:2000;95-102.
68. Olszewski P.K., Shaw T.J., Grace M.K., Billington C.J., Levine A.S. Nocistatin inhibits food intake in rats. Brain Res. 872:2000;181-187.
69. Olszewski P.K., Shi Q., Billington C.J., Levine A.S. Opioids affect acquisition of LiCl-induced conditioned taste aversion: involvement of OT and VP systems. Am. J. Physiol., Regul. Integr. Comp. Physiol. 279:2000;R1504-R1511.
70. Olszewski P.K., Grace M.K., Sanders J.B., Billington C.J., Levine A.S. Effect of nociceptin/orphanin FQ on food intake in rats that differ in diet preference. Pharmacol. Biochem. Behav. 73:2002;529-535.
71. O'Shea T.M., Kothadia J.M., Klinepeter K.L., Goldstein D.J., Jackson B.G., Weaver R.G. III, Dillard R.G. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 104:1999;15-21.
72. Pan Y.X., Xu J., Pasternak G.W. Cloning and expression of a cDNA encoding a mouse brain orphanin FQ/nociceptin precursor. Biochem. J. 315(Pt. 1):1996;11-13.
73. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. NeuroReport. 8:1996;369-371.
74. Pu L., Bao G.B., Ma L., Pei G. Acute desensitization of nociceptin/orphanin FQ inhibition of voltage-gated calcium channels in freshly dissociated hippocampal neurons. Eur. J. Neurosci. 11:1999;3610-3616.
75. Reinscheid R.K., Civelli O. The orphanin FQ/nociceptin knockout mouse: a behavioral model for stress responses. Neuropeptides. 36:2002;72-76.
76. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
77. Reinscheid R.K., Ardati A., Monsma F.J. Jr., Civelli O. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J. Biol. Chem. 271:1996;14163-14168.
78. Saito Y., Maruyama K., Saido T.C., Kawashima S. N23K, a gene transiently up-regulated during neural differentiation, encodes a precursor protein for a newly identified neuropeptide nociceptin. Biochem. Biophys. Res. Commun. 217:1995;539-545.
79. Saito Y., Maruyama K., Kawano H., Hagino-Yamagishi K., Kawamura K., Saido T.C., Kawashima S. Molecular cloning and characterization of a novel form of neuropeptide gene as a developmentally regulated molecule. J. Biol. Chem. 271:1996;15615-15622.
80. Saito Y., Maruyama K., Saido T.C., Kawashima S. Overexpression of a neuropeptide nociceptin/orphanin FQ precursor gene, N23K/N27K, induces neurite outgrowth in mouse NS20Y cells. J. Neurosci. Res. 48:1997;397-406.
81. Sandin J., Georgieva J., Schott P.A., Ogren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur. J. Neurosci. 9:1997;194-197.
82. Sinchak K., Hendricks D.G., Baroudi R., Micevych P.E. Orphanin FQ/nociceptin in the ventromedial nucleus facilitates lordosis in female rats. NeuroReport. 8:1997;3857-3860.
83. Sirianni M.J., Fujimoto K.I., Nelson C.S., Pellegrino M.J., Allen R.G. Cyclic AMP analogs induce synthesis, processing, and secretion of prepro nociceptin/orphanin FQ-derived peptides by NS20Y neuroblastoma cells. DNA Cell Biol. 18:1999;51-58.
84. Slugg R.M., Ronnekleiv O.K., Grandy D.K., Kelly M.J. Activation of an inwardly rectifying K+ conductance by orphanin-FQ/nociceptin in vasopressin-containing neurons. Neuroendocrinology. 69:1999;385-396.
85. Sousa R.J., Tannery N.H., Lafer E.M. In situ hybridization mapping of glucocorticoid receptor messenger ribonucleic acid in rat brain. Mol. Endocrinol. 3:1989;481-494.
86. van Eekelen J.A., Bohn M.C., de Kloet E.R. Postnatal ontogeny of mineralocorticoid and glucocorticoid receptor gene expression in regions of the rat tel- and diencephalon. Brain Res. Dev. Brain Res. 61:1991;33-43.
87. Vaughan C.W., Christie M.J. Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br. J. Pharmacol. 117:1996;1609-1611.
88. Vaughan C.W., Ingram S.L., Christie M.J. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17:1997;996-1003.
89. Wagner E.J., Ronnekleiv O.K., Grandy D.K., Kelly M.J. The peptide orphanin FQ inhibits beta-endorphin neurons and neurosecretory cells in the hypothalamic arcuate nucleus by activating an inwardly rectifying K+ conductance. Neuroendocrinology. 67:1998;73-82.
90. Wang J.B., Johnson P.S., Imai Y., Persico A.M., Ozenberger B.A., Eppler C.M., Uhl G.R. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. 348:1994;75-79.
91. Wick M.J., Minnerath S.R., Lin X., Elde R., Law P.Y., Loh H.H. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Res. Mol. Brain Res. 27:1994;37-44.
92. Wu Y.L., Pu L., Ling K., Zhao J., Cheng Z.J., Ma L., Pei G. Molecular characterization and functional expression of opioid receptor-like 1 receptor. Cell Res. 7:1997;69-77.